Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.48 |
| ▸ | CYSLTR1 | Q9Y271 | 8/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.47 |
| ▸ | CYSLTR2 | Q9NS75 | 4/20 | 0.45 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8034921 | 1.00 | ALOX5 (0.53) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8029102 | 0.85 | CYSLTR1 (0.53) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8029106 | 0.85 | CYSLTR1 (0.53) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL7801525 | 0.85 | MAPT (0.56) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8029126 | 0.84 | ALOX5 (0.48) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8029128 | 0.84 | ALOX5 (0.48) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8034999 | 0.84 | ALOX5 (0.47) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8034993 | 0.84 | ALOX5 (0.47) | ALOX5PDE10ACYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8523069 | 0.84 | MAOB (0.56) | ALOX5PDE10ALTB4R | |
| SCHEMBL8523071 | 0.84 | MAOB (0.56) | ALOX5PDE10ALTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6166031-A | Substituted tetralins, chromans and related compounds in the treatment of asthma | PFIZER INC, (US) | 2000-12-26 | — | — | US | disclosed |
| US-5998451-A | LIPOXYGENASE INHIBITORS | PFIZER INC (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0313296-B1 | Substituted chromans and related compounds in the treatment of asthma | PFIZER (US) | 1993-12-29 | — | — | EP | disclosed |
| EP-0313295-B1 | SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA, ARTHRITIS AND RELATED DISEASES | PFIZER INC. (US) | 1993-07-28 | — | — | EP | disclosed |
| US-5059609-A | Lipoxygenase inhibitors; leukotriene receptor blockers; psoriasis; antiulcer agents and myocardial infarctions | PFIZER INC. (US) | 1991-10-22 | — | — | US | disclosed |
| WO-1989003681-A1 | SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA | PFIZER INC. (US) | 1989-05-05 | — | — | WO | disclosed |
| EP-0313296-A2 | Substituted chromans and related compounds in the treatment of asthma | PFIZER INC. (US) | 1989-04-26 | — | — | EP | disclosed |
| EP-0313295-A2 | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases | PFIZER INC. (US) | 1989-04-26 | — | — | EP | disclosed |